EBSA23 - Luxembourg - Conference program

28 April 2021

17:30 Welcome reception and opening exhibition

Day 1 - 29 April 2021

08:45 Opening
09:00 Welcome
Thomas Binz, EBSA President
09:10 Welcome local
09:30 Key-note: The ecology of the unseen
Paul Wilmes, Unversity of Luxembourg
10:00 Coffee and exhibition

Session 1a - Cell and gene therapy

Session 1b - Food (safety)


Jan De Rijck, Celyad, Belgium

Is science soluble in the assessment of GMO risks in Europe?
Patrick du Jardin, University of Liège, Belgium


Critical biosafety issues related to the application of GMO investigational medicinal products in clinical trials
Ursula Jenal, Jenal & Partners, Switzerland


CRISPR technology: Overview and safety aspects
Dalia Seger, Weizmann Institute Of Science, Israël

The Hellenic Food Safety Authority’s Mission through the Case Study of Ready-to-eat Salads in Greek Markets.
Soultana Tatsika, Hellenic Food Safety Authority, Greece
  Lunch and exhibition

Poster Session

Product / service presentations

  service presentation 1a service presentation 2a


service presentation 1b service presentation 2b

Chris Collins lecture

15:00 Coffee

Session 2 Emerging technologies and (bio)safety


Gene editing - Technical & safety aspects
Michele Garfinkel, EMBO, Germany

16:00 Gene editing - Ethical and regulatory aspects
Patrick Rüdelsheim, PlantEd

Containment of gene drive mosquitoes
Alissia Cagnetti, Polo d’Innovazione di Genomica Genetica e Biologia (PoloGGB), Italy

17:00 AGM - EBSA Annual General Assembly  
19:30 Conference dinner      

premium sponsor/exhibitor

Profile sponsor exhibitor




Day 2 - 30 April 2021

08:30 Coffee

Session 3 Emerging resistance


Rational use of biocides and alternative methods in the hospital – Dr. Phillppe Carenco, CHR in Hyere (FR)


Measurement of aerosol generation
Allan Bennett, Public Health England (UK)


Field study: Chemical inactivation of liquid cell culture waste
Charlotte Ruhnau, Cantonal Laboratory Basel-City, Switzerland

10:30 Coffee
11:00 Break out 1 Break out 2 Break out 3 Break out 4 Break out 5 Break out 6

Gene drives – EFSA guidance consultation outcome (discussion)
Remote presentation by Yann Devos (EFSA) Local moderation by Patrick Rüdelsheim (Be)

Biological related legislation (ABP, Nagoya, dual use, waste, transport etc.) - Delphine Beeckman (Be) and Marcel van Bergen (NL) Recombinant vaccines / clinical evaluation - working group with authorities to develop
guidance document (discussion) - Katia Pauwels, Sciensano (Be) - Eric van den  Akker RIVM (NL)

Biosafety when scaling up a process, from research scale to industrial scale, what are the critical parameters to keep in mind ?

Henry-Michel CAUCHIE (Lu)


National Organisations - TBC

12:30 Lunch

Session 4 Kombucha  


Feedback from break-outs and EBSA focal points


Session 5 - WHO Manual discussion session
Moderator: Allan Bennett PHE (UK) and Kazunobo Kojima, WHO (UK)

15:00 Keynote: GAPIII Polio containment initiative and its role in global biorisk management
Eugene Saxentoff, WHO - DEC (Denmark)
15:30 Closure
Thomas Binz, EBSA President 2019-2021




Register now!

Fees in EURO

  Conference Conference dinner Conference book
EBSA member Early bird until February 28th 2021 418 euro 50 euro 25 euro
> March 1st 2021 468 euro 50 euro 25 euro
non-member Early bird until February 28th 2021 538 euro 50 euro 25 euro
> March 1st 2021 588 euro 50 euro 25 euro

All prices are including local Luxembourg VAT

premium sponsor/exhibitor

Profile sponsor exhibitor